Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · IEX Real-Time Price · USD
0.428
+0.012 (2.89%)
At close: Jul 26, 2024, 3:54 PM
0.430
+0.002 (0.47%)
After-hours: Jul 26, 2024, 7:36 PM EDT
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $3.25 million as of July 26, 2024. Its market cap has increased by 29.83% in one year.
Market Cap
3.25M
Enterprise Value
87.32K
1-Year Change
29.83%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since December 1, 2017, Ensysce Biosciences's market cap has decreased from $249.00M to $3.25M, a decrease of -98.70%. That is a compound annual growth rate of -47.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 3.10M | -6.06% |
| Dec 29, 2023 | 3.30M | -40.00% |
| Dec 30, 2022 | 5.50M | -95.18% |
| Dec 31, 2021 | 114.00M | 46.34% |
| Dec 31, 2020 | 77.90M | -70.10% |
| Dec 31, 2019 | 260.50M | 6.11% |
| Dec 31, 2018 | 245.50M | -0.89% |
| Dec 29, 2017 | 247.70M | -0.52% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 3.15M |
| Xylo Technologies | 3.13M |
| CNS Pharmaceuticals | 3.10M |
| Akanda | 3.09M |
| ZyVersa Therapeutics | 3.08M |
| Fresh2 Group | 3.00M |
| NovaBay Pharmaceuticals | 2.91M |
| Alzamend Neuro | 2.91M |